emtricitabine/rilpivirine/ tenofovir alafenamide

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

HIV-1 infection

Manufacturer:

Gilead Sciences Canada, Inc.

Call for patient/clinician input open:

October 27, 2016

Brand Name:

Odefsey

Project Line:

Reimbursement Review

Project Number:

SR0507-000

Call for patient/clinician input closed:

December 15, 2016

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

HIV-1 infection

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

May 25, 2017

Last Updated : October 27, 2016